RevBio

United States
Arlington Heights, Illinois, United States, 01854

Company profile

RevBio company profile

RevBio is commercializing an injectable, self-setting, osteoconductive bone adhesive biomaterial that can bond bone to bone and bone to metal in a wet field environment. The company's showcase product, Tetranite, is being reviewed by the FDA for a growing body of applications including oral, craniofacial, orthopedic, and neurosurgical indications. Over time, this synthetic adhesive biodegrades and is replaced by new bone. This unique material will reduce the duration and complexity of medical procedures, allow for more minimally invasive surgeries, and will improve patient outcomes by reducing recovery time and the overall cost of care.

Business identity

Contact email
[email protected]
Phone number
617-947-6246
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$1M-$10M
Founded
2014-07-16

Headquarters

Postal code
01854
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding rounds
22
Total equity funding
$18.5M
Last funding
Grant / $2.2M / 2025-10-06
Last equity funding
Corporate Round
Investors
15
Lead investors
8
Founders
5
Articles
28

Founders and investors

Founders

Andrey MarchenkoBrian HessGeorge KayGrayson AllenJonathan Reese Slotkin

Lead investors

MedTech InnovatorNational Institute of Dental and Craniofacial Research (NIDCR)National Institute of HealthNational Institute of Neurological Disorders and StrokeNational Institute on AgingNational Institutes of HealthPacific Dental ServicesTranslational Resource Center

Investors

Delta Dental of Rhode IslandMassChallengeNational Institute of Neurological Disorders and StrokeNational Institute on AgingNational Institutes of Health